{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:13:24Z","timestamp":1788970404546,"version":"build-2803163510"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aims to investigate the risk factors associated with additional intraoperative procedures during post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) in patients with advanced germ-cell tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed the data of 206 patients who underwent PC-RPLND for advanced germ-cell tumors between January 1990 and December 2022. Additional intraoperative procedures were defined as surgical interventions necessitated by injuries to intestinal, ureteral, major vascular, or renal vascular structures, as well as planned en-bloc resections. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of these additional procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 67 additional procedures were performed in 56 patients (27.2%). The most frequent interventions were vascular procedures (aortic, caval, or renal vessel repairs), occurring in 40 patients (19.4%). This was followed by en-bloc nephrectomy in 10 (4.9%), intestinal injury repair in 9 (4.4%), and ureteral injury repair in 8 (3.9%) patients. Multivariate analysis revealed that tumor size at initial diagnosis (P\u00a0&amp;lt;\u00a0.05) and the presence of viable tumor in the pathology specimen (P\u00a0&amp;lt;\u00a0.05) were independent risk factors for requiring additional intraoperative procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Tumor size at the time of initial diagnosis, rather than preoperative size, serves as a significant predictor for additional surgical procedures during PC-RPLND. Surgical planning should account for initial tumor burden and the likelihood of viable disease to optimize perioperative outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jjco\/hyag088","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:43:03Z","timestamp":1778845383000},"page":"1128-1132","source":"Crossref","is-referenced-by-count":0,"title":["Are we missing an important point? Risk factors for intraoperative complications and additional procedures when performing post-chemotherapy RPLND for testicular tumors"],"prefix":"10.1093","volume":"56","author":[{"given":"Mesut","family":"Altan","sequence":"first","affiliation":[{"name":"Hacettepe University, Faculty of Medicine, Department of Urology , 06100 Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5197-3230","authenticated-orcid":false,"given":"Hakan","family":"Keskin","sequence":"additional","affiliation":[{"name":"Hacettepe University, Faculty of Medicine, Department of Urology , 06100 Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sertac","family":"Yazici","sequence":"additional","affiliation":[{"name":"Hacettepe University, Faculty of Medicine, Department of Urology , 06100 Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2026090910435337300_ref1","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.puhe.2007.10.010","article-title":"Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm?","volume":"122","author":"Holmes","year":"2008","journal-title":"Public Health"},{"key":"2026090910435337300_ref2","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1200\/JCO.1990.8.11.1777","article-title":"Treatment of testicular cancer: a new and improved model","volume":"8","author":"Einhorn","year":"1990","journal-title":"J Clin Oncol"},{"key":"2026090910435337300_ref3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ejca.2005.08.043","article-title":"Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: an update based on meta-analysis","volume":"42","author":"Dijk","year":"2006","journal-title":"Eur J Cancer"},{"key":"2026090910435337300_ref4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-319-56114-1_9","volume-title":"Principles and Practice of Urooncology: Radiotherapy, Surgery and Systemic Therapy","author":"Akdo\u011fan","year":"2017"},{"key":"2026090910435337300_ref5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.soc.2006.10.003","article-title":"Retroperitoneal lymph node dissection in testicular cancer","volume":"16","author":"Jacobsen","year":"2007","journal-title":"Surg Oncol Clin N Am"},{"key":"2026090910435337300_ref6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1200\/JCO.2005.05.4791","article-title":"Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma","volume":"25","author":"Carver","year":"2007","journal-title":"J Clin Oncol"},{"key":"2026090910435337300_ref7","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0959-8049(00)00137-4","article-title":"The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients","volume":"36","author":"Andr\u00e9","year":"2000","journal-title":"Eur J Cancer"},{"key":"2026090910435337300_ref8","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1200\/JCO.2003.01.019","article-title":"Chemotherapy for teratoma with malignant transformation","volume":"21","author":"Donadio","year":"2003","journal-title":"J Clin Oncol"},{"key":"2026090910435337300_ref9","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/cncr.22181","article-title":"Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?","volume":"107","author":"Spiess","year":"2006","journal-title":"Cancer"},{"key":"2026090910435337300_ref10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10147-020-01786-8","article-title":"Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors","volume":"26","author":"Altan","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"2026090910435337300_ref11","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1200\/JCO.2001.19.10.2647","article-title":"Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy\u2014results from an international study group","volume":"19","author":"Fizazi","year":"2001","journal-title":"J Clin Oncol"},{"key":"2026090910435337300_ref12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.eururo.2008.09.027","article-title":"Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection","volume":"55","author":"Heidenreich","year":"2009","journal-title":"Eur Urol"},{"key":"2026090910435337300_ref13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.eururo.2011.10.045","article-title":"Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group","volume":"61","author":"Winter","year":"2012","journal-title":"Eur Urol"},{"key":"2026090910435337300_ref14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.urology.2016.01.010","article-title":"Characterizing the morbidity of postchemotherapy retroperitoneal lymph node dissection for testis cancer in a national cohort of privately insured patients","volume":"91","author":"Macleod","year":"2016","journal-title":"Urology"},{"key":"2026090910435337300_ref15","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1097\/01.ju.0000120141.89737.90","article-title":"Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer","volume":"171","author":"Mosharafa","year":"2004","journal-title":"J Urol"},{"key":"2026090910435337300_ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/189823","article-title":"Hospital surgical volume, utilization, costs and outcomes of retroperitoneal lymph node dissection for testis cancer","volume":"2012","author":"Yu","year":"2012","journal-title":"Adv Urol"},{"key":"2026090910435337300_ref17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0022-5347(01)67616-X","article-title":"Complications of post-chemotherapy retroperitoneal lymph node dissection","volume":"153","author":"Baniel","year":"1995","journal-title":"J Urol"},{"key":"2026090910435337300_ref18","doi-asserted-by":"publisher","first-page":"389.e15","DOI":"10.1016\/j.urolonc.2014.07.013","volume-title":"Urologic Oncology: Seminars and Original Investigations","author":"Cary","year":"2015"},{"key":"2026090910435337300_ref19","doi-asserted-by":"publisher","first-page":"rjy358","DOI":"10.1093\/jscr\/rjy358","article-title":"Spontaneous regression as a \u2018burned-out\u2019 non-seminomatous testicular germ cell tumor: a case report and literature review","volume":"2019","author":"Dorantes-Heredia","year":"2019","journal-title":"J Surg Case Rep"},{"key":"2026090910435337300_ref20","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0022-5347(05)64275-9","article-title":"Management of post-chemotherapy residual masses in advanced seminoma","volume":"168","author":"Flechon","year":"2002","journal-title":"J Urol"},{"key":"2026090910435337300_ref21","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1097\/01.ju.0000060121.33899.4b","article-title":"Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?","volume":"169","author":"Mosharafa","year":"2003","journal-title":"J Urol"},{"key":"2026090910435337300_ref22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1046\/j.1464-410x.1999.00974.x","article-title":"The management of residual masses after chemotherapy in metastatic seminoma","volume":"83","author":"Ravi","year":"1999","journal-title":"BJU Int"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/9\/1128\/68454917\/hyag088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/9\/1128\/68454917\/hyag088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:32:16Z","timestamp":1788967936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/56\/9\/1128\/8700084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,6,2]]},"published-print":{"date-parts":[[2026,9,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyag088","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,6,2]]}}}